Targeting the anthrax receptors, TEM-8 and CMG-2, for anti-angiogenic therapy

Frontiers in Bioscience

Volumn 16, Issue 4, 2011, Pages 1574-1588

  Cryan, Lorna M ^a   Rogers, Michael S ^a  

^a Children's Hospital   (United Kingdom)

Author keywords

Angiogenesis; Anthrax; Endothelial; Extracellular matrix; Intracellular signaling; Review

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTHRAX TOXIN; ANTINEOPLASTIC AGENT; ANTXR1 PROTEIN, HUMAN; ANTXR2 PROTEIN, HUMAN; BACTERIAL ANTIGEN; BACTERIAL TOXIN; CELL SURFACE RECEPTOR; MEMBRANE PROTEIN; TUMOR PROTEIN;

ANIMAL; DRUG EFFECT; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; GENETICS; HUMAN; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PHYSIOLOGY; REVIEW;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTIGENS, BACTERIAL; ANTINEOPLASTIC AGENTS; BACTERIAL TOXINS; ENDOTHELIAL CELLS; EXTRACELLULAR MATRIX; HUMANS; MEMBRANE PROTEINS; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, CELL SURFACE;

EID: 79955020782     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3806     Document Type: Article

References (87)

1. Bell, S. E., A. Mavila, R. Salazar, K. J. Bayless, S. Kanagala, S. A. Maxwell & G. E. Davis: Differential gene expression during capillary morphogenesis in 3D collagen matrices: regulated expression of genes involved in basement membrane matrix assembly, cell cycle progression, cellular differentiation and G-protein signaling. J Cell Sci, 114, 2755-73 (2001) (Pubitemid 32785455)
2. Scobie, H. M., G. J. Rainey, K. A. Bradley & J. A. Young: Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor. Proc Natl Acad Sci U S A, 100, 5170-4 (2003) (Pubitemid 36542677)
3. St Croix, B., C. Rago, V. Velculescu, G. Traverso, K. E. Romans, E. Montgomery, A. Lal, G. J. Riggins, C. Lengauer, B. Vogelstein & K. W. Kinzler: Genes expressed in human tumor endothelium. Science, 289, 1197-202 (2000) (Pubitemid 30650733)
4. Mock, M. & A. Fouet: Anthrax. Annu Rev Microbiol, 55, 647-71 (2001) (Pubitemid 32978119)
5. Bradley, K. A., J. Mogridge, M. Mourez, R. J. Collier & J. A. Young: Identification of the cellular receptor for anthrax toxin. Nature, 414, 225-9 (2001) (Pubitemid 33051239)
6. Klimpel, K. R., N. Arora & S. H. Leppla: Anthrax toxin lethal factor contains a zinc metalloprotease consensus sequence which is required for lethal toxin activity. Mol Microbiol, 13, 1093-100 (1994) (Pubitemid 24300720)
7. Duesbery, N. S., C. P. Webb, S. H. Leppla, V. M. Gordon, K. R. Klimpel, T. D. Copeland, N. G. Ahn, M. K. Oskarsson, K. Fukasawa, K. D. Paull & G. F. Vande Woude: Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science, 280, 734-7 (1998) (Pubitemid 28243347)
8. Robertson, D. L., M. T. Tippetts & S. H. Leppla: Nucleotide sequence of the Bacillus anthracis edema factor gene (cya): a calmodulin-dependent adenylate cyclase. Gene, 73, 363-71 (1988) (Pubitemid 19043269)
9. Abrami, L., S. H. Leppla & F. G. van der Goot: Receptor palmitoylation and ubiquitination regulate anthrax toxin endocytosis. J Cell Biol, 172, 309-20 (2006) (Pubitemid 43112976)
10. Abrami, L., M. Bischofberger, B. Kunz, R. Groux & F. G. van der Goot: Endocytosis of the anthrax toxin is mediated by clathrin, actin and unconventional adaptors. PLoS Pathog, 6, e1000792 (2010)
11. Cullen, M., S. Seaman, A. Chaudhary, M. Y. Yang, M. B. Hilton, D. Logsdon, D. C. Haines, L. Tessarollo & B. St Croix: Host-Derived Tumor Endothelial Marker 8 Promotes the Growth of Melanoma. Cancer Res (2009)
12. Liu, S., D. Crown, S. Miller-Randolph, M. Moayeri, H. Wang, H. Hu, T. Morley & S. H. Leppla: Capillary morphogenesis protein-2 is the major receptor mediating lethality of anthrax toxin in vivo. Proc Natl Acad Sci U S A (2009)
13. Dowling, O., A. Difeo, M. C. Ramirez, T. Tukel, G. Narla, L. Bonafe, H. Kayserili, M. Yuksel-Apak, A. S. Paller, K. Norton, A. S. Teebi, V. Grum-Tokars, G. S. Martin, G. E. Davis, M. J. Glucksman & J. A. Martignetti: Mutations in capillary morphogenesis gene-2 result in the allelic disorders juvenile hyaline fibromatosis and infantile systemic hyalinosis. Am J Hum Genet, 73, 957-66 (2003) (Pubitemid 37271897)
14. Jinnin, M., D. Medici, L. Park, N. Limaye, Y. Liu, E. Boscolo, J. Bischoff, M. Vikkula, E. Boye & B. R. Olsen: Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma. Nat Med, 14, 1236-46 (2008)
15. Carson-Walter, E. B., D. N. Watkins, A. Nanda, B. Vogelstein, K. W. Kinzler & B. St Croix: Cell surface tumor endothelial markers are conserved in mice and humans. Cancer Res, 61, 6649-55 (2001) (Pubitemid 32896479)
16. Liu, S. & S. H. Leppla: Cell surface tumor endothelium marker 8 cytoplasmic tail-independent anthrax toxin binding, proteolytic processing, oligomer formation, and internalization. J Biol Chem, 278, 5227-34 (2003) (Pubitemid 36801035)
17. Bradley, K. A., J. Mogridge, G. Jonah, A. Rainey, S. Batty & J. A. Young: Binding of anthrax toxin to its receptor is similar to alpha integrin-ligand interactions. J Biol Chem, 278, 49342-7 (2003)
18. Wigelsworth, D. J., B. A. Krantz, K. A. Christensen, D. B. Lacy, S. J. Juris & R. J. Collier: Binding stoichiometry and kinetics of the interaction of a human anthrax toxin receptor, CMG2, with protective antigen. J Biol Chem, 279, 23349-56 (2004) (Pubitemid 38685644)
19. Lacy, D. B., D. J. Wigelsworth, H. M. Scobie, J. A. Young & R. J. Collier: Crystal structure of the von Willebrand factor A domain of human capillary morphogenesis protein 2: an anthrax toxin receptor. Proc Natl Acad Sci U S A, 101, 6367-72 (2004) (Pubitemid 38585980)
20. Scobie, H. M., D. Thomas, J. M. Marlett, G. Destito, D. J. Wigelsworth, R. J. Collier, J. A. Young & M. Manchester: A soluble receptor decoy protects rats against anthrax lethal toxin challenge. J Infect Dis, 192, 1047-51 (2005) (Pubitemid 41266802)
21. Gu, J., V. Faundez & E. Werner: Endosomal recycling regulates anthrax toxin receptor 1/tumor endothelial marker 8-dependent cell spreading. Exp Cell Res, In Press, Corrected Proof, (2010)
22. Abrami, L., B. Kunz & F. G. van der Goot: Anthrax toxin triggers the activation of src-like kinases to mediate its own uptake. Proc Natl Acad Sci U S A, 107, 1020-24 (2010)
23. Reeves, C. V., J. Dufraine, J. A. Young & J. Kitajewski: Anthrax toxin receptor 2 is expressed in murine and tumor vasculature and functions in endothelial proliferation and morphogenesis. Oncogene (2009)
24. Bonuccelli, G., F. Sotgia, P. G. Frank, T. M. Williams, C. J. de Almeida, H. B. Tanowitz, P. E. Scherer, K. A. Hotchkiss, B. I. Terman, B. Rollman, A. Alileche, J. Brojatsch & M. P. Lisanti: ATR/TEM8 is highly expressed in epithelial cells lining Bacillus anthracis' three sites of entry: implications for the pathogenesis of anthrax infection. Am J Physiol Cell Physiol, 288, C1402-10 (2005) (Pubitemid 40991077)
25. Nanda, A., E. B. Carson-Walter, S. Seaman, T. D. Barber, J. Stampfl, S. Singh, B. Vogelstein, K. W. Kinzler & B. St Croix: TEM8 interacts with the cleaved C5 domain of collagen alpha 3 (VI). Cancer Res, 64, 817-20 (2004) (Pubitemid 38176877)
26. Hotchkiss, K. A., C. M. Basile, S. C. Spring, G. Bonuccelli, M. P. Lisanti & B. I. Terman: TEM8 expression stimulates endothelial cell adhesion and migration by regulating cell-matrix interactions on collagen. Exp Cell Res, 305, 133-44 (2005) (Pubitemid 40380660)
27. Herrmann, D., A. Ferrer-Vaquer, C. Lahsnig, N. Firnberg, A. Leibbrandt & A. Neubuser: Expression and regulation of ANTXR1 in the chick embryo. Dev Dyn, 239, 680-7 (2010)
28. Abrami, L., B. Kunz, J. Deuquet, A. Bafico, G. Davidson & F. G. van der Goot: Functional interactions between anthrax toxin receptors and the WNT signalling protein LRP6. Cell Microbiol, 10, 2509-19 (2008)
29. Lohler, J., R. Timpl & R. Jaenisch: Embryonic lethal mutation in mouse collagen I gene causes rupture of blood vessels and is associated with erythropoietic and mesenchymal cell death. Cell, 38, 597-607 (1984) (Pubitemid 14022052)
30. Whelan, M. C. & D. R. Senger: Collagen I initiates endothelial cell morphogenesis by inducing actin polymerization through suppression of cyclic AMP and protein kinase A. J Biol Chem, 278, 327-34 (2003) (Pubitemid 36043580)
31. Herbst, T. J., J. B. McCarthy, E. C. Tsilibary & L. T. Furcht: Differential effects of laminin, intact type IV collagen, and specific domains of type IV collagen on endothelial cell adhesion and migration. J Cell Biol, 106, 1365-73 (1988)
32. Dejana, E., L. R. Languino, N. Polentarutti, G. Balconi, J. J. Ryckewaert, M. J. Larrieu, M. B. Donati, A. Mantovani & G. Marguerie: Interaction between fibrinogen and cultured endothelial cells. Induction of migration and specific binding. J Clin Invest, 75, 11-8 (1985) (Pubitemid 15163960)
33. Wijelath, E. S., S. Rahman, M. Namekata, J. Murray, T. Nishimura, Z. Mostafavi-Pour, Y. Patel, Y. Suda, M. J. Humphries & M. Sobel: Heparin-II domain of fibronectin is a vascular endothelial growth factor-binding domain: enhancement of VEGF biological activity by a singular growth factor/matrix protein synergism. Circ Res, 99, 853-60 (2006) (Pubitemid 44556384)
34. Jimenez, B., O. V. Volpert, S. E. Crawford, M. Febbraio, R. L. Silverstein & N. Bouck: Signals leading to poptosisdependent inhibition of neovascularization by thrombospondin-1. Nat Med, 6, 41-8 (2000) (Pubitemid 30048524)
35. Iruela-Arispe, M. L., P. Bornstein & H. Sage: Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro. Proc Natl Acad Sci U S A, 88, 5026-30 (1991) (Pubitemid 21914676)
36. Streit, M., L. Riccardi, P. Velasco, L. F. Brown, T. Hawighorst, P. Bornstein & M. Detmar: Thrombospondin-2: a potent endogenous inhibitor of tumor growth and angiogenesis. Proc Natl Acad Sci U S A, 96, 14888-93 (1999) (Pubitemid 30019735)
37. Grant, D. S., C. Yenisey, R. W. Rose, M. Tootell, M. Santra & R. V. Iozzo: Decorin suppresses tumor cellmediated angiogenesis. Oncogene, 21, 4765-77 (2002) (Pubitemid 34879452)
38. Davies Cde, L., R. J. Melder, L. L. Munn, C. Mouta-Carreira, R. K. Jain & Y. Boucher: Decorin inhibits endothelial migration and tube-like structure formation: role of thrombospondin-1. Microvasc Res, 62, 26-42 (2001) (Pubitemid 32679304)
39. Kamphaus, G. D., P. C. Colorado, D. J. Panka, H. Hopfer, R. Ramchandran, A. Torre, Y. Maeshima, J. W. Mier, V. P. Sukhatme & R. Kalluri: Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth. J Biol Chem, 275, 1209-15 (2000) (Pubitemid 30051173)
40. Petitclerc, E., A. Boutaud, A. Prestayko, J. Xu, Y. Sado, Y. Ninomiya, M. P. Sarras, Jr., B. G. Hudson & P. C. Brooks: New functions for non-collagenous domains of human collagen type IV. Novel integrin ligands inhibiting angiogenesis and tumor growth in vivo. J Biol Chem, 275, 8051-61 (2000) (Pubitemid 30159718)
41. Staton, C. A., N. J. Brown, G. R. Rodgers, K. P. Corke, S. Tazzyman, J. C. Underwood & C. E. Lewis: Alphastatin, a 24-amino acid fragment of human fibrinogen, is a potent new inhibitor of activated endothelial cells in vitro and in vivo. Blood, 103, 601-6 (2004) (Pubitemid 38140093)
42. Yi, M. & E. Ruoslahti: A fibronectin fragment inhibits tumor growth, angiogenesis, and metastasis. Proc Natl Acad Sci U S A, 98, 620-4 (2001) (Pubitemid 32105092)
43. Ferrari do Outeiro-Bernstein, M. A., S. S. Nunes, A. C. Andrade, T. R. Alves, C. Legrand & V. Morandi: A recombinant NH (2)-terminal heparin-binding domain of the adhesive glycoprotein, thrombospondin-1, promotes endothelial tube formation and cell survival: a possible role for syndecan-4 proteoglycan. Matrix Biol, 21, 311-24 (2002) (Pubitemid 34786469)
44. Werner, E., A. P. Kowalczyk & V. Faundez: Anthrax toxin receptor 1/tumor endothelium marker 8 mediates cell spreading by coupling extracellular ligands to the actin cytoskeleton. J Biol Chem, 281, 23227-36 (2006)
45. Wei, W., Q. Lu, G. J. Chaudry, S. H. Leppla & S. N. Cohen: The LDL receptor-related protein LRP6 mediates internalization and lethality of anthrax toxin. Cell, 124, 1141-54 (2006)
46. Ryan, P. L. & J. A. Young: Evidence against a human cell-specific role for LRP6 in anthrax toxin entry. PLoS One, 3, e1817 (2008)
47. Young, J. J., J. L. Bromberg-White, C. Zylstra, J. T. Church, E. Boguslawski, J. H. Resau, B. O. Williams & N. S. Duesbery: LRP5 and LRP6 are not required for protective antigen-mediated internalization or lethality of anthrax lethal toxin. PLoS Pathog, 3, e27 (2007)
48. Kato, M., M. S. Patel, R. Levasseur, I. Lobov, B. H. Chang, D. A. Glass, 2nd, C. Hartmann, L. Li, T. H. Hwang, C. F. Brayton, R. A. Lang, G. Karsenty & L. Chan: Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J Cell Biol, 157, 303-14 (2002) (Pubitemid 34839826)
49. Xu, Q., Y. Wang, A. Dabdoub, P. M. Smallwood, J. Williams, C. Woods, M. W. Kelley, L. Jiang, W. Tasman, K. Zhang & J. Nathans: Vascular development in the retina and inner ear: control by Norrin and Frizzled-4, a highaffinity ligand-receptor pair. Cell, 116, 883-95 (2004) (Pubitemid 38410732)
50. Masckauchan, T. N., D. Agalliu, M. Vorontchikhina, A. Ahn, N. L. Parmalee, C. M. Li, A. Khoo, B. Tycko, A. M. Brown & J. Kitajewski: Wnt5a signaling induces proliferation and survival of endothelial cells in vitro and expression of MMP-1 and Tie-2. Mol Biol Cell, 17, 5163-72 (2006) (Pubitemid 44907359)
51. Masckauchan, T. N., C. J. Shawber, Y. Funahashi, C. M. Li & J. Kitajewski: Wnt/beta-catenin signaling induces proliferation, survival and interleukin-8 in human endothelial cells. Angiogenesis, 8, 43-51 (2005) (Pubitemid 41223838)
52. Wright, M., M. Aikawa, W. Szeto & J. Papkoff: Identification of a Wnt-responsive signal transduction pathway in primary endothelial cells. Biochem Biophys Res Commun, 263, 384-8 (1999) (Pubitemid 29467205)
53. Krugmann, S., K. E. Anderson, S. H. Ridley, N. Risso, A. McGregor, J. Coadwell, K. Davidson, A. Eguinoa, C. D. Ellson, P. Lipp, M. Manifava, N. Ktistakis, G. Painter, J. W. Thuring, M. A. Cooper, Z. Y. Lim, A. B. Holmes, S. K. Dove, R. H. Michell, A. Grewal, A. Nazarian, H. Erdjument-Bromage, P. Tempst, L. R. Stephens & P. T. Hawkins: Identification of ARAP3, a novel PI3K effector regulating both Arf and Rho GTPases, by selective capture on phosphoinositide affinity matrices. Mol Cell, 9, 95-108 (2002) (Pubitemid 34127774)
54. I, S. T., Z. Nie, A. Stewart, M. Najdovska, N. E. Hall, H. He, P. A. Randazzo & P. Lock: ARAP3 is transiently tyrosine phosphorylated in cells attaching to fibronectin and inhibits cell spreading in a RhoGAP-dependent manner. J Cell Sci, 117, 6071-84 (2004) (Pubitemid 40136469)
55. Krugmann, S., L. Stephens & P. T. Hawkins: Purification of ARAP3 and characterization of GAP activities. Methods Enzymol, 406, 91-103 (2006) (Pubitemid 43207434)
56. Rmali, K. A., M. C. Puntis & W. G. Jiang: TEM-8 and tubule formation in endothelial cells, its potential role of its vW/TM domains. Biochem Biophys Res Commun, 334, 231-8 (2005) (Pubitemid 40978530)
57. Go, M. Y., E. M. Chow & J. Mogridge: The cytoplasmic domain of anthrax toxin receptor 1 affects binding of the protective antigen. Infect Immun, 77, 52-9 (2009)
58. Hlatky, L., P. Hahnfeldt & J. Folkman: Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us. J Natl Cancer Inst, 94, 883-93 (2002) (Pubitemid 34778087)
59. Rogers, M. S., K. A. Christensen, A. E. Birsner, S. M. Short, D. J. Wigelsworth, R. J. Collier & R. J. D'Amato: Mutant anthrax toxin B moiety (protective antigen) inhibits angiogenesis and tumor growth. Cancer Res, 67, 9980-5 (2007) (Pubitemid 47621248)
60. Gordon, V. M., K. R. Klimpel, N. Arora, M. A. Henderson & S. H. Leppla: Proteolytic activation of bacterial toxins by eukaryotic cells is performed by furin and by additional cellular proteases. Infect Immun, 63, 82-7 (1995)
61. Fernando, S. & B. S. Fletcher: Targeting tumor endothelial marker 8 in the tumor vasculature of colorectal carcinomas in mice. Cancer Res, 69, 5126-32 (2009)
62. Ruan, Z., Z. Yang, Y. Wang, H. Wang, Y. Chen, X. Shang, C. Yang, S. Guo, J. Han, H. Liang & Y. Wu: DNA vaccine against tumor endothelial marker 8 inhibits tumor angiogenesis and growth. J Immunother, 32, 486-91 (2009)
63. Duan, H. F., X. W. Hu, J. L. Chen, L. H. Gao, Y. Y. Xi, Y. Lu, J. F. Li, S. R. Zhao, J. J. Xu, H. P. Chen, W. Chen & C. T. Wu: Antitumor activities of TEM8-Fc: an engineered antibody-like molecule targeting tumor endothelial marker 8. J Natl Cancer Inst, 99, 1551-5 (2007) (Pubitemid 351767233)
64. Mazurek, S., C. B. Boschek, F. Hugo & E. Eigenbrodt: Pyruvate kinase type M2 and its role in tumor growth and spreading. Semin Cancer Biol, 15, 300-8 (2005) (Pubitemid 41058775)
65. Mazurek, S., H. Grimm, M. Oehmke, G. Weisse, S. Teigelkamp & E. Eigenbrodt: Tumor M2-PK and glutaminolytic enzymes in the metabolic shift of tumor cells. Anticancer Res, 20, 5151-4 (2000) (Pubitemid 32319099)
66. Venanzi, F. M., M. Petrini, L. Fiammenghi, E. Bolli, A. M. Granato, L. Ridolfi, F. Gabrielli, A. Barucca, A. Concetti, R. Ridolfi & A. Riccobon: Tumor endothelial marker 8 expression levels in dendritic cell-based cancer vaccines are related to clinical outcome. Cancer Immunol Immunother (2009)
67. Rouleau, C., K. Menon, P. Boutin, C. Guyre, H. Yoshida, S. Kataoka, M. Perricone, S. Shankara, A. E. Frankel, N. S. Duesbery, G. Vande Woude, H. P. Biemann & B. A. Teicher: The systemic administration of lethal toxin achieves a growth delay of human melanoma and neuroblastoma xenografts: assessment of receptor contribution. Int J Oncol, 32, 739-48 (2008) (Pubitemid 351780584)
68. Felicetti, P., M. Mennecozzi, A. Barucca, S. Montgomery, F. Orlandi, K. Manova, A. N. Houghton, P. D. Gregor, A. Concetti & F. M. Venanzi: Tumor endothelial marker 8 enhances tumor immunity in conjunction with immnization against differentiation Ag. Cytotherapy, 9, 23-34 (2007)
69. Arora, N. & S. H. Leppla: Residues 1-254 of anthrax toxin lethal factor are sufficient to cause cellular uptake of fused polypeptides. J Biol Chem, 268, 3334-41 (1993) (Pubitemid 23070965)
70. Liu, S., H. Aaronson, D. J. Mitola, S. H. Leppla & T. H. Bugge: Potent antitumor activity of a urokinase-activated engineered anthrax toxin. Proc Natl Acad Sci U S A, 100, 657-62 (2003) (Pubitemid 36126108)
71. Liu, S., T. H. Bugge & S. H. Leppla: Targeting of tumor cells by cell surface urokinase plasminogen activator-dependent anthrax toxin. J Biol Chem, 276, 17976-84 (2001)
72. Liu, S., S. Netzel-Arnett, H. Birkedal-Hansen & S. H. Leppla: Tumor cell-selective cytotoxicity of matrix metalloproteinase-activated anthrax toxin. Cancer Res, 60, 6061-7 (2000)
73. Liu, S., H. Wang, B. M. Currie, A. Molinolo, H. J. Leung, M. Moayeri, J. R. Basile, R. W. Alfano, J. S. Gutkind, A. E. Frankel, T. H. Bugge & S. H. Leppla: Matrix metalloproteinase-activated anthrax lethal toxin demonstrates high potency in targeting tumor vasculature. J Biol Chem, 283, 529-40 (2008)
74. Liu, S., V. Redeye, J. G. Kuremsky, M. Kuhnen, A. Molinolo, T. H. Bugge & S. H. Leppla: Intermolecular complementation achieves high-specificity tumor targeting by anthrax toxin. Nat Biotechnol, 23, 725-30 (2005) (Pubitemid 41716363)
75. Chen, K. H., S. Liu, L. A. Bankston, R. C. Liddington & S. H. Leppla: Selection of anthrax toxin protective antigen variants that discriminate between the cellular receptors TEM8 and CMG2 and achieve targeting of tumor cells. J Biol Chem, 282, 9834-45 (2007) (Pubitemid 47104586)
76. Duesbery, N. S., J. Resau, C. P. Webb, S. Koochekpour, H. M. Koo, S. H. Leppla & G. F. Vande Woude: Suppression of ras-mediated transformation and inhibition of tumor growth and angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple MEK pathways. Proc Natl Acad Sci U S A, 98, 4089-94 (2001) (Pubitemid 32249903)
77. Koo, H. M., M. VanBrocklin, M. J. McWilliams, S. H. Leppla, N. S. Duesbery & G. F. Woude: Apoptosis and melanogenesis in human melanoma cells induced by anthrax lethal factor inactivation of mitogen-activated protein kinase kinase. Proc Natl Acad Sci U S A, 99, 3052-7 (2002) (Pubitemid 34240584)
78. Huang, D., Y. Ding, W. M. Luo, S. Bender, C. N. Qian, E. Kort, Z. F. Zhang, K. VandenBeldt, N. S. Duesbery, J. H. Resau & B. T. Teh: Inhibition of MAPK kinase signaling pathways suppressed renal cell carcinoma growth and angiogenesis in vivo. Cancer Res, 68, 81-8 (2008) (Pubitemid 351380108)
79. Abi-Habib, R. J., J. O. Urieto, S. Liu, S. H. Leppla, N. S. Duesbery & A. E. Frankel: BRAF status and mitogenactivated protein/extracellular signal-regulated kinase kinase 1/2 activity indicate sensitivity of melanoma cells to anthrax lethal toxin. Mol Cancer Ther, 4, 1303-10 (2005)
80. Alfano, R. W., S. H. Leppla, S. Liu, T. H. Bugge, M. Herlyn, K. S. Smalley, J. L. Bromberg-White, N. S. Duesbery & A. E. Frankel: Cytotoxicity of the matrix metalloproteinase-activated anthrax lethal toxin is dependent on gelatinase expression and B-RAF status in human melanoma cells. Mol Cancer Ther, 7, 1218-26 (2008)
81. Alfano, R. W., S. H. Leppla, S. Liu, T. H. Bugge, J. M. Ortiz, T. C. Lairmore, N. S. Duesbery, I. C. Mitchell, F. Nwariaku & A. E. Frankel: Inhibition of tumor angiogenesis by the matrix metalloproteinase-activated anthrax lethal toxin in an orthotopic model of anaplastic thyroid carcinoma. Mol Cancer Ther, 9, 190-201 (2010)
82. Bromberg-White, J. L., E. Boguslawski & N. S. Duesbery: Perturbation of mouse retinal vascular morphogenesis by anthrax lethal toxin. PLoS One, 4, e6956 (2009)
83. Ding, Y., E. A. Boguslawski, B. D. Berghuis, J. J. Young, Z. Zhang, K. Hardy, K. Furge, E. Kort, A. E. Frankel, R. V. Hay, J. H. Resau & N. S. Duesbery: Mitogen-activated protein kinase kinase signaling promotes growth and vascularization of fibrosarcoma. Mol Cancer Ther, 7, 648-58 (2008) (Pubitemid 351482147)
84. Warfel, J. M., A. D. Steele & F. D'Agnillo: Anthrax lethal toxin induces endothelial barrier dysfunction. Am J Pathol, 166, 1871-81 (2005) (Pubitemid 40734409)
85. Alfano, R. W., S. H. Leppla, S. Liu, T. H. Bugge, C. J. Meininger, T. C. Lairmore, A. F. Mulne, S. H. Davis, N. S. Duesbery & A. E. Frankel: Matrix metalloproteinaseactivated anthrax lethal toxin inhibits endothelial invasion and neovasculature formation during in vitro morphogenesis. Mol Cancer Res, 7, 452-61 (2009)
86. Kirby, J. E.: Anthrax lethal toxin induces human endothelial cell apoptosis. Infect Immun, 72, 430-9 (2004) (Pubitemid 38018204)
87. Hong, J., R. C. Doebele, M. W. Lingen, L. A. Quilliam, W. J. Tang & M. R. Rosner: Anthrax edema toxin inhibits endothelial cell chemotaxis via Epac and Rap1. J Biol Chem, 282, 19781-7 (2007) (Pubitemid 47100121)